01Read the project-defined identity literally

Novum’s supplied 10 mg Adamax report calls the material a modified Semax-type project reference. Its conclusion says that identity is defined by the qualified project reference and LC-HRMS fingerprint; it also states that Adamax nomenclature is not standardised.Supplied Adamax 10 mg report (opens in a new tab)

The report does not print a full amino-acid sequence, molecular formula or complete description of covalent modifications. It therefore provides a reference-based identity statement without giving the reader a self-contained structural definition.Supplied Adamax 10 mg report (opens in a new tab)

That limitation is not proof that the material has a particular alternative structure. It is a reason to preserve an unresolved field instead of silently completing it from another website.

02An official mention does not resolve the molecule

A June 2025 Medsafe classification proposal names Adamax and Semax when discussing ACTH analogues marketed as cognitive enhancers. The passage shows the name appearing in a regulatory discussion; it does not supply an Adamax sequence or an experimental demonstration of cognitive effects.Medsafe — June 2025 peptide classification proposal (opens in a new tab)

The word marketed describes the claims surrounding a product. It should not be converted into an agency finding that those claims are established.

Likewise, a proposed classification document has a different purpose from a structure-elucidation paper. Here it is used only to identify the context in which the name appears, not to state current UK law or validate a supplier’s chemical description.

A broad relationship to Semax can guide discovery searches, but it cannot identify which residues or terminal groups have changed. Those details determine whether a retrieved Semax experiment is directly relevant or merely background.

03Remove name collisions before counting research

AdaMax also appears in Kingma and Ba’s original optimisation paper as a computational algorithm. That is a genuine scholarly result for the same letter sequence, but it is unrelated to peptide identity or biological activity.Kingma and Ba — Adam: A Method for Stochastic Optimization (opens in a new tab)

This makes a raw search-result count especially unhelpful. Adding peptide, sequence and chemical-identity terms can improve discovery, but the final inclusion decision still requires reading the source.

For each candidate paper, record its actual test material. If it studies Semax without identifying an Adamax modification, classify it as related-compound background rather than direct Adamax evidence.

The sources checked for this article do not establish a complete public structure-to-study chain for the supplied material. That is a bounded conclusion about the checked evidence, not a claim that no relevant document could exist anywhere.

04Specify the missing evidence in useful terms

A useful identity packet would name the exact sequence, all terminal and side-chain modifications, relevant stereochemistry and the chemical form of the reference. It would then connect that reference to the material discussed in any claimed supporting study.

If such documentation becomes available, compare the structures directly before adding efficacy language. A matching nickname or similar mass alone would leave important ambiguities unresolved.

Until the identity chain is available, Adamax content can accurately explain the supplied documentation and the limits of related research. It should not inherit Semax findings as though a modification necessarily preserves the same activity, distribution or safety.